True Wealth Design LLC Raises Stake in CME Group Inc. (NASDAQ:CME)

True Wealth Design LLC grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 15.4% during the fourth quarter, Holdings Channel reports. The firm owned 668 shares of the financial services provider’s stock after purchasing an additional 89 shares during the period. True Wealth Design LLC’s holdings in CME Group were worth $155,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. SeaCrest Wealth Management LLC boosted its position in shares of CME Group by 5.4% in the 4th quarter. SeaCrest Wealth Management LLC now owns 1,339 shares of the financial services provider’s stock worth $311,000 after buying an additional 69 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. increased its position in CME Group by 40.4% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 271 shares of the financial services provider’s stock worth $63,000 after purchasing an additional 78 shares in the last quarter. Carnegie Investment Counsel increased its position in CME Group by 7.9% during the 4th quarter. Carnegie Investment Counsel now owns 11,348 shares of the financial services provider’s stock worth $2,635,000 after purchasing an additional 834 shares in the last quarter. Ritholtz Wealth Management increased its position in CME Group by 11.5% during the 4th quarter. Ritholtz Wealth Management now owns 4,035 shares of the financial services provider’s stock worth $937,000 after purchasing an additional 417 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC purchased a new position in CME Group in the 4th quarter worth approximately $301,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on CME shares. UBS Group increased their target price on CME Group from $290.00 to $305.00 and gave the company a “buy” rating in a research note on Friday, April 25th. Oppenheimer increased their target price on CME Group from $269.00 to $279.00 and gave the stock an “outperform” rating in a research report on Friday, April 11th. Barclays raised their price target on CME Group from $279.00 to $283.00 and gave the company an “equal weight” rating in a report on Wednesday, April 23rd. Keefe, Bruyette & Woods lifted their target price on CME Group from $265.00 to $273.00 and gave the stock a “market perform” rating in a report on Thursday, April 24th. Finally, Erste Group Bank raised CME Group to a “strong-buy” rating in a report on Monday, March 17th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $256.80.

CME Group Price Performance

Shares of NASDAQ CME opened at $276.29 on Friday. The firm has a market cap of $99.56 billion, a P/E ratio of 28.57, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $286.48. The business’s 50 day moving average is $265.86 and its 200-day moving average is $247.18.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping analysts’ consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 13.62% and a net margin of 57.52%. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the company earned $2.50 EPS. The company’s revenue was up 10.4% on a year-over-year basis. Equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.81%. The ex-dividend date of this dividend is Monday, June 9th. CME Group’s payout ratio is presently 50.30%.

Insiders Place Their Bets

In other news, COO Suzanne Sprague sold 1,500 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now owns 8,036 shares in the company, valued at $2,063,885.88. The trade was a 15.73% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of the stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total value of $997,872.48. Following the sale, the insider now owns 27,046 shares in the company, valued at approximately $6,774,211.62. This represents a 12.84% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 23,134 shares of company stock valued at $6,087,434. 0.30% of the stock is currently owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.